Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
By 19961998, Novo Nordisk researchers were already leaders in insulin science, but peptides beyond insulin were still unfamiliar territory
In Eli Lillys Phase 3 TRIUMPH-4 trial (December 2025), participants at the 12mg dose lost an average of 28.7% of body weight at 68 weeks up to 71.2 lbs per person
We do not ask patients to stop or decrease medications before treatment
While an 11.2 percent average weight loss is clinically significant, it trails behind the 13.7 percent average reduction seen with semaglutide and 20.2 percent with tirzepatide
What is the exact refund window, and what specific circumstances qualify for a refund
US$ 25.94
US$ 20.88
US$ 24.28
US$ 25.50
